Warning Signs at the DMV

Amritpal’s interest in the field of eye health began with a personal battle to preserve his own vision. In 2014, Amritpal was taking a simple vision exam during his driver’s test when he discovered that his eyesight had declined considerably since his last check-up.

The sixteen-year-old had always worn glasses to correct the vision in his left eye, but standing in the DMV, Amritpal was unable to pass the exam. During follow-up optometrist visits, he was diagnosed with a lazy eye, but his vision and eye health continued to deteriorate.

A Path to Treatment

Seeking a second opinion, Amritpal was referred to an ophthalmologist and was told his symptoms were consistent with an eye disease called keratoconus. Known as “KC,” this degenerative condition causes progressive thinning and bulging of the cornea, leading to declining vision and for some patients, eventual blindness.

A keratoconus specialist then diagnosed Amritpal with keratoconus in both his right and left eyes, leading to conversations about how best to manage the condition. He chose to undergo an innovative treatment option called corneal cross-linking, which had the potential to slow the progression of his keratoconus, as an alternative to more traditional treatments like a corneal transplant.

A Life Dedicated to Eye Health

Amritpal’s involvement in managing his condition and choosing to undergo cross-linking not only led to an interest in eye health, but a decision to dedicate his life to medicine. He is currently a 3rd-year Biology major at the New Jersey Institute of Technology and will be applying to the SUNY College of Optometry after graduation. He is working towards becoming an optometrist with a cornea specialty and wants to use his own experience to help others make informed choices about their eye health.

Click here to read more KC Journeys.

The results described on this site are based on data collected regarding short- and intermediate-term efficacy of treatment. Individual results are not guaranteed and may vary.